Effects of Limicol on LDL-cholesterol

Not Applicable

Completed

• Conditions: Hypercholesteremia
• Interventions: Dietary Supplement: Limicol; Dietary Supplement: Placebo

• Registration Number: NCT01354327
• Lead Sponsor: Lescuyer Laboratory

Brief Summary

The principal objective of this study is to investigate the effects of a novel food supplement (Limicol) on LDL-cholesterol levels in healthy subjects with moderate hypercholesterolemia.

Detailed Description

Not available

Study Timeline

• Study Start: 2008-12
• Status Verified: 2011-05
• Primary Completion: 2011-05
• Study Completion: 2011-05
• Study First Submitted: 2011-05-13
• Study First Submitted QC: 2011-05-13
• Last Update Submitted: 2011-05-13
• Study First Posted: 2011-05-16
• Last Update Posted: 2011-05-16

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 47

Inclusion Criteria

• About 18 to 55 years (inclusive)
• Subject has a stable weight for at least three months before the start of the study
• Subject able and willing to comply with the protocol and agreeing to give their consent in writing
• Subject affiliated with a social security scheme
• Subject willing to be included in the national register of volunteers who lend themselves to biomedical research

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Limicol	Limicol	-
Placebo	Placebo	-

Primary Outcome Measures

Name	Time	Method
Change from Baseline in blood LDL-cholesterol levels at 4 months	4 months

Secondary Outcome Measures

Name	Time	Method
Change from Baseline in blood Vit. C, Vit. E, polyphenols and MDA levels at 4 months	4 months

Trial Locations

Locations (1)

Morange; 🇫🇷 Marseille, France